Basaglar ‘Copycat’ Insulin for Diabetes Has Advantages Over Lantus

Real-world study confirms Basaglar is as safe and effective in type 2 diabetes as Lantus, both formulations of insulin glargine, but the former was cheaper and had better adherence.
Medscape Medical News

Leave a Reply

Your email address will not be published.